Venture Capital Archives - Life Sciences Times

1910 Genetics Opens its First Dedicated Laboratory and Office Facility in Boston’s Seaport District

November 18, 2021

University of Pittsburgh Gets a $100 Million Grant to Transform the Region into a Life Sciences Powerhouse

November 17, 2021

Bit.bio Appoints Accomplished Biotechnology Executive and Drug Developer Kathryn Corzo as Chief Operating Officer

November 17, 2021

Colliers Advises Vibalogics in 118,000-SF Life Science Deal in Boxborough

November 13, 2020

New England Biolabs Leases 28,000 SF

December 7, 2020

Boston Properties Announces 138,000 Square Foot, 10-Year Lease With Translate Bio in Waltham, Massachusetts

November 10, 2020

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Venture Capital

causaLens Raises $45m Series A to Scale Human-centered AI That Understands Cause-and-effect

BioVentrix Expands Heart Failure Treatment Portfolio with Acquisition of MateraCor, Inc.

Broad Sky Partners Announces Investment From Capital Constellation and Acquisition of Thomas Scientific

Interchecks Announces $16M Series B Financing, Co-led by Senator Investment Group and Standard Investments, to Accelerate Instant Payment Infrastructure

o9 Solutions Raises $295 Million From Strategic Investors to Continue its Growth Across Industry Verticals & Markets

Most Read

Merck and Ridgeback’s Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Demonstrated Activity Against Omicron Variant in In Vitro Studies

causaLens Raises $45m Series A to Scale Human-centered AI That Understands Cause-and-effect

Insulet Announces FDA Clearance of its Omnipod® 5 Automated Insulin Delivery System, First Tubeless System with Smartphone Control

First Patient Recruited for Multi-Year Collaborative Primary Sclerosing Cholangitis (PSC) Pediatric Study Using Perspectum’s Imaging Technology to Help Predict Disease Progression and Guide Patient...

EDITOR PICKS